+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

The effects of type beta transforming growth factor on proliferation and epidermal growth factor receptor expression in a human glioblastoma cell line



The effects of type beta transforming growth factor on proliferation and epidermal growth factor receptor expression in a human glioblastoma cell line



Journal of Neuro-Oncology 6(3): 269-276



Type beta transforming growth factor (B-TGF) is a potent growth inhibitor to many human tumor cell lines. Very little is known about the mechanism for this growth inhibitory action of B-TGF. We here report the effect of B-TGF on proliferation and epidermal growth factor receptor (R-EGF) expression in a human glioblastoma cell line named T-MG1. B-TGF inhibited the soft agar growth of T-MG1 cells. Maximum inhibition was 70%, achieved with 0.5 units B-TGF. B-TGF had no effect on monolayer growth of T-MG1 cells. T-MG1 cells contained abundant R-EGF, which could be divided into two subpopulations, one high affinity and one low affinity population of R-EGF. Treatment with B-TGF caused an initial decrease (0-6 h) in EGF- binding, followed by an increase in EGF-binding which reached maximum after 24 exposure to B-TGF. Since addition of EGF to agar cultures gave no additional increase in inhibition by B-TGF and EGF alone had no inhibitory effect, we believe that binding of EGF to its receptor is not part of the pathway mediating the inhibitory effect of B-TGF. All neoplastic cells have lost some measure of growth control and the cellular elements involved are growth factors, growth factor receptors and oncogenes. T-MG1 cells contain abundant R-EGF and this may partly explain their malignant nature (malignant nature is here defined as ability to proliferate in agarose). Type alpha transforming growth factors, which in some cancer cells act as uncontrolled autocrine growth factors, were not found in protein extracts from T-MG1 cells. B-TGF, which is normally found in all cells, could not be detected in protein extracts from T-MG1 cells. The lack of B-TGF as an autocrine growth inhibitor may be of importance for maintaining the malignant nature of T-MG1 cells.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 007897864

Download citation: RISBibTeXText

PMID: 3265719

DOI: 10.1007/bf00163712


Related references

Type beta transforming growth factor and epidermal growth factor suppress the plasminogen activator activity in a human glioblastoma cell line. Journal of Neuro-Oncology 6(3): 277-284, 1988

Comparison of the ability of basic and acidic fibroblast growth factor to stimulate the proliferation of an established keratinocyte cell line: modulation of their biological effects by heparin, transforming growth factor beta (TGF beta), and epidermal growth factor (EGF). Journal of Cellular Physiology 142(2): 325-333, 1990

Modulation of epidermal growth factor receptor gene expression by transforming growth factor-beta in a human breast carcinoma cell line. Cancer Research 47(16): 4260-4265, 1987

Effects of type beta transforming growth factor in combination with retinoic acid or tumor necrosis factor on proliferation of a human glioblastoma cell line and clonogenic cells from freshly resected human brain tumors. Cancer Immunology Immunotherapy 26(3): 273-279, 1988

Modulation of epidermal growth factor receptor gene expression by triiodothyronine and transforming growth factor beta in a human breast carcinoma cell line. Journal Of Cellular Biochemistry Supplementrt A: 120, 1988

Analysis of transforming growth factor (TGF)-alpha/epidermal growth factor receptor, hepatocyte growth Factor/c-met,TGF-beta receptor type II, and p53 expression in human hepatocellular carcinomas. Clinical Cancer Research 3(7): 1059-1066, 1997

Altered gene expression of c myc epidermal growth factor receptor transforming growth factor alpha and c erb b2 in an immortalized human breast epithelial cell line hmt 3522 is associated with decreased growth factor requirements. Cancer Research 52(5): 1210-1217, 1992

Epidermal growth factor attenuates cell proliferation by down-regulating the transforming growth factor-beta receptor in the osteoblastic cell line MC3T3-E1. Bone and Mineral 15(2): 125-135, 1991

Autocrine growth mechanism by transforming growth factor (TGF)-beta 1 and TGF-beta 1-receptor regulation by epidermal growth factor in a human endometrial cancer cell line IK-90. International Journal of Cancer 54(5): 862-867, 1993

Epidermal growth factor up-regulates expression of transforming growth factor beta receptor type II in human dermal fibroblasts by phosphoinositide 3-kinase/Akt signaling pathway: Resistance to epidermal growth factor stimulation in scleroderma fibroblasts. Arthritis and Rheumatism 48(6): 1652-1666, 2003

Activation of epidermal growth factor receptor gene is involved in transforming growth factor-beta-mediated fibronectin expression in a chondrocyte progenitor cell line. International Journal of Molecular Medicine 25(4): 593-600, 2010

Expression of epidermal growth factor and transforming growth factor beta in a human salivary gland adenocarcinoma cell line. Cancer Research 45(12 Part 1): 6160-6167, 1985

Effects of platelet derived growth factor pdgf epidermal growth factor egf and transforming growth factor beta tgf beta on the proliferation of human chorionic villi cells. American Journal of Human Genetics 43(3 Suppl.): A240, 1988

Different expression of genes for glioblastoma derived t cell suppressor factor transforming growth factor beta 2 and transforming growth factor beta 1 in human brain tumor cells. Lymphokine Research 7(3): 281, 1988

Expression of transforming growth factor beta , transforming growth factor alpha and epidermal growth factor receptor in renal cell carcinoma. Journal of Urology 155(5 Suppl. ): 656A, 1996